My stance is that.
A: FDA gives favorable PIII sending stock higher
B: FDA requires difficult PIII sned ing stock lower
C: FDA says AA is not premauture anymore sending stock parabolic
Are you kidding me? Those lawsuits area total joke brought on by impatient investors and shorts. If you were smart you doubled down at $12pps almost a triple
Data is so/so to say the least and FDA grants AA. SRPT has superior safety and efficacy data in a fatal disorder and it's "premature for AA". Makes a whole lot of sense to me. Geez! Wake up FDA